Back to Journals » Breast Cancer: Targets and Therapy » Volume 14
Original Research
Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,347 | Dovepress* | 3,919+ | 185 | 4,104 | |
PubMed Central* | 428 | 199 | 627 | ||
Totals | 4,347 | 384 | 4,731 | ||
*Since 9 December 2022 |
View citations on PubMed Central and Google Scholar